Publications by authors named "Neil Lava"

Claim this Profile
P
Patient-Specific Out-of-Pocket Cost Communication and Remote Financial Navigation in Patients with Multiple Sclerosis: A Randomized Controlled Feasibility Study.
Gelareh Sadigh, Debrua Coleman, Neil Lava, Jeffrey Switchenko, Diana Vargas

Mult Scler Relat Disord· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes of financial hardship in patients with multiple sclerosis.
Gelareh Sadigh, Jeffrey Switchenko, Neil Lava, Richard Duszak, Elizabeth A Krupinski

Mult Scler Relat Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromyelitis Optica Presenting as Infectious Meningoencephalitis: Case Report and Literature Review.
Mohamad Ali H Tfaily, Boghuma Titanji, Matthew J Schniederjan, Abigail Goodman, Neil S Lava

Am J Med Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence.
Gelareh Sadigh, Neil Lava, Jeffrey Switchenko, Richard Duszak, Elizabeth A Krupinski

Mult Scler· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions and experiences of multiple sclerosis patients regarding out-of-pocket costs of care discussions.
Gracie Tewkesbury, Ruth C Carlos, Richard Duszak, Elizabeth A Krupinski, Jeffrey Switchenko, Neil Lava

Mult Scler Relat Disord· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Robert J Fox, Christopher S Coffey, Robin Conwit, Merit E Cudkowicz, Trevis Gleason, Neil Lava

N Engl J Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Robert J Fox, Christopher S Coffey, Merit E Cudkowicz, Trevis Gleason, Andrew Goodman, Neil Lava

Contemp Clin Trials· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).
Robert Zivadinov, Diane L Cookfair, Lauren Krupp, Aaron E Miller, Neil Lava

BMC Neurol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Jakob Habib, Jiusheng Deng, Neil Lava, William Tyor, Jacques Galipeau

J Mult Scler (Foster City)· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy.
Stewart A Factor, Jiang Qian, Neil S Lava, Jeffrey D Hubbard, Haydeh Payami

Ann Neurol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis